RL
Ronald L. Anderson
Co-Founder, President, Chief Executive Officer, Chairman of the Board
Rithim BiologicsTherapeutic Areas
Rithim Biologics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Gene Therapy for Atrial Tachyarrhythmias | Fast heart rates originating in the atria (e.g., Atrial Fibrillation) | Pre-clinical |
| Gene Therapy for Ventricular Tachyarrhythmias | Fast heart rates originating in the ventricles | Pre-clinical |